Position in ARVN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,957,188
-$1,072,543 QoQ
Shares Held
476,196
+0.4% QoQ
Ownership
0.728%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 198 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. ARVN ranks #16 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in ARVN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,957,188 | 476,196 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $5,029,731 | 474,503 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,876,357 | 495,477 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $4,751,961 | 557,742 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $3,190,471 | 433,488 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $1,643,423 | 234,106 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,464,423 | 232,886 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $5,509,484 | 223,690 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $6,286,951 | 236,174 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $11,413,176 | 276,482 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $11,472,814 | 278,737 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $5,598,460 | 285,054 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,231,580 | 291,361 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $8,471,658 | 310,090 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $9,372,000 | 273,955 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,329,806 | 29,890 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $375,442 | 8,920 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $254,595 | 3,783 | Shares | Sole | 2022-04-11 | |
| No filing history on record for this holder in this stock. | ||||||